Properties
Description
Vecabrutinib is a compound designed to block Bruton’s tyrosine kinase (BTK), an enzyme essential for the proliferation and survival of certain cancerous B cells.
Molecular Formula
C22H24ClF4N7O2
Identity
Confirmed by NMR/HPLC/MS.
Applications
Vecabrutinib is used to research its inhibitory effects on BTK, relevant for managing autoimmune diseases and B-cell lymphomas.